Navigating the Medicare Coverage Maze: Challenges and Policy Solutions

As Medicare open enrollment begins next month, millions of Americans will assess their coverage options. Should they choose traditional Medicare or opt for a private Medicare Advantage plan?

What about private prescription drug plans and Medigap plans that cover services that Medicare does not? With so many choices and marketing messages, how do consumers make these decisions?

On September 22, 2023, speakers discussed new research on people’s experiences with Medicare marketing, what factors and information influence Medicare coverage choices, and potential policy

opportunities to better support consumers during open enrollment.

Introduction:

Presenters:

Associate, Commonwealth Fund

The presenters were followed by a discussion moderated by Julie Rovner, Chief Washington Correspondent at KFF Health News. Panelists include:

Healthcare Information and Counseling, Administration for Community Living (ACL)Sarah Murdoch, M.S.W., Director of Client Services, Medicare Rights CenterMaricruz Rivera-Hernandez, Ph.D.,

Assistant Professor of Health Services, Policy and Practice, Brown University

MORE FROM AARP

Prices for Top Medicare Part D Drugs Have More Than Tripled Since Entering the Market

List prices for 25 top Medicare Part D drugs have increased by an average of 226 percent—or more than tripled—since they first entered the market.

PPI Events

The AARP Solutions Forums brings together the nation’s experts to discuss options for addressing problems facing older Americans { "maxItems":3, "itemsPerRow":"3", "rows":"4",

"loadMore":"6", "adsNum":"0", "resultsLength":"2" }